bioMérieux S.A. (OTCMKTS:BMXMF – Get Free Report) passed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $114.85 and traded as high as $120.85. bioMérieux shares last traded at $120.85, with a volume of 1 shares traded.
bioMérieux Trading Up 0.7 %
The firm’s 50-day simple moving average is $114.85 and its 200-day simple moving average is $112.55. The company has a quick ratio of 1.20, a current ratio of 2.21 and a debt-to-equity ratio of 0.10.
About bioMérieux
bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.
Featured Stories
- Five stocks we like better than bioMérieux
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- How to Invest in the Best Canadian Stocks
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for bioMérieux Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioMérieux and related companies with MarketBeat.com's FREE daily email newsletter.
